Transgenomic Shares Down 11 Percent; Nasdaq Warning Imminent | GenomeWeb

NEW YORK, March 28 (GenomeWeb News) - Shares in Transgenomic were down 11.11 percent, or $.07, at $.56 in early-afternoon trading --- a few cents above their 52-week low --- prompting the likelihood that the company may get a delisting warning letter from the Nasdaq exchange on Wednesday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.